NASDAQ: NKTR Long Term Investor Alert: Investigation of Potential Wrongdoing at Nektar Therapeutics
Certain directors of Nektar Therapeutics are under investigation on behalf of current long-term investors in shares of Nektar Therapeutics (NASDAQ: NKTR) concerning potential breaches of fiduciary duties by certain directors and officers of Nektar Therapeutics was announced.
View full press release